COMMUNIQUÉS West-GlobeNewswire

Virbac : Declaration of the number of shares and voting rights as of January 2018, 31.
02/02/2018
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Virbac : Déclaration d'actions et de droits de vote au 31 Janvier 2018
02/02/2018
DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]
Jørgen Erichsen, Executive Vice President, Natural Colors Division, to leave Chr. Hansen Holding A/S
02/02/2018
http://prlibrary-eu.nasdaq.com/Resource/Download/716c8dc2-71b7-41d8-933d-5a6b13663ecc
Appointment of Jonathan E. Gold as Interim Chief Financial Officer
02/02/2018
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ) ("Motif Bio" or the "Company"), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today [...]
TESARO to Announce Fourth-Quarter 2017 Financial Results on February 27, 2018
02/02/2018
WALTHAM, Mass., Feb. 02, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ) will announce fourth-quarter 2017 financial results on Tuesday, February 27, 2018, after the close of the U.S. financial markets. During the [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 1 February 2018
02/02/2018
Bagsværd, Denmark, 2 February 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]
Knalysis Technologies is On the Move
02/02/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Knalysis Technologies “Knalysis”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV [...]
Cambrex to Announce Fourth Quarter and Full Year 2017 Financial Results on February 8, 2018
02/02/2018
EAST RUTHERFORD, N,J., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
Abeona Therapeutics Announces Upcoming Presentations at the 14th Annual WORLDSymposium
02/02/2018
NEW YORK and CLEVELAND, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
Onconova Announces Presentation of Mechanism of Action Studies of Rigosertib Combination with Azacitidine at American Association for Cancer Epigenetics Research Conference
02/02/2018
NEWTOWN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today [...]
Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT
02/02/2018
MINNEAPOLIS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc , formerly Skyline Medical Inc, (NASDAQ: SKLN ) (NASDAQ: AIPT ) (“Precision Therapeutics” or the “Company”), is pleased to announce that its [...]
Sorrento Therapeutics CEO Dr Ji to Present at LEERINK Partners 7th Global Healthcare Conference on 02/15/18
02/02/2018
SAN DIEGO, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it will present at LEERINK Partners 7th Annual Global Healthcare Conference (Lotte New York [...]
Aclaris Therapeutics to Attend Upcoming Investor Conferences
02/02/2018
MALVERN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]
Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Leipzig Interventional Course 2018
02/02/2018
REDWOOD CITY, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that its next generation Pantheris® [...]
Arcturus Therapeutics Appoints Mark Herbert as Interim President
02/02/2018
SAN DIEGO, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today announced that Mark R. Herbert, Vice President of Business Development and Alliance [...]
The American Health Council Appoints Theresa Gutierrez, MSN, RN, FNP to Nursing Board
02/02/2018
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Theresa Gutierrez, MSN, RN, FNP, has been appointed to the American Health Council’s Nursing Board. Ms. Gutierrez brings an abundance of experience from spending 21 years [...]
PetVivo Holdings, Inc. Approaches Commercial Production
02/02/2018
MINNEAPOLIS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- A long-awaited day is approaching for PetVivo Holdings, Inc. ( www.petvivo.com ) (OTCMARKETS:PETV), an emerging biomedical device company. We are speaking of commercial [...]
Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe
02/02/2018
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that physicians in Europe [...]
Extendicare Announces Timing of 2017 Fourth Quarter and Year End Results and Conference Call
02/02/2018
MARKHAM, Ontario, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today that it plans to release its financial results for the fourth quarter and year ended [...]

Pages